Standard InChI: InChI=1S/C23H24FN3O/c1-16-4-2-5-20-22(16)25-21(26-23(20)28)6-3-13-27-14-11-18(12-15-27)17-7-9-19(24)10-8-17/h2,4-5,7-11H,3,6,12-15H2,1H3,(H,25,26,28)
1.Hattori K, Kido Y, Yamamoto H, Ishida J, Iwashita A, Mihara K.. (2007) Rational design of conformationally restricted quinazolinone inhibitors of poly(ADP-ribose)polymerase., 17 (20):[PMID:17804225][10.1016/j.bmcl.2007.07.091]
2.Zhang WT, Ruan JL, Wu PF, Jiang FC, Zhang LN, Fang W, Chen XL, Wang Y, Cao BS, Chen GY, Zhu YJ, Gu J, Chen JG.. (2009) Design, synthesis, and cytoprotective effect of 2-aminothiazole analogues as potent poly(ADP-ribose) polymerase-1 inhibitors., 52 (3):[PMID:19125579][10.1021/jm800902t]
3.Wang YQ, Wang PY, Wang YT, Yang GF, Zhang A, Miao ZH.. (2016) An Update on Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy., 59 (21):[PMID:27416328][10.1021/acs.jmedchem.6b00055]